DAVAO CITY, January 25 (PIA) - In the hope of further increasing the number of vaccinated individuals against COVID19, the Department of Health (DOH) XI is also preparing for the vaccination rollout in medical clinics.
DOH XI clarified that the rollout is conducted in a phased approach. The Phase 2 will cover additional vaccination sites in NCR as determined by the NVOC. The Phase 3 will expand the rollout in other regions, depending on site readiness as determined by the Center for Health Development.
As soon as Phase 3 will be implemented, vaccination in medical clinics in the region will then start to accommodate individuals 12 years and above under all priority groups: Priority Group A1 (health workers), Expanded Priority group A1, Priority Group 3, Group 3 Pregnant Women, Pediatric A3 or 12 to 17 years old and with co-morbidities, A4 or workers in essential service, A5 or poor population, the rest of the adult population, and the rest of the pediatric population.
Vaccination in medical clinics would cover the administration of primary dose series and booster doses of all priority groups.
Vaccine brands allowed for administration in medical clinics are Sinovac, Astrazeneca, Sinopharm, Janssen, Pfizer, and Moderna.
Meanwhile, the LGUs are to provide oversight to the implementation of vaccination services in medical clinics and to serve as the implementing unit. (PIA XI/Frances Mae Macapagat)
Comments
Post a Comment